Inflammatory disseminated superficial porokeratosis successfully controlled with a combination of topical diclofenac gel and systemic etretinate

J Eur Acad Dermatol Venereol. 2018 May;32(5):e201-e202. doi: 10.1111/jdv.14727. Epub 2017 Dec 18.

Authors

S Shimizu¹, Y Takashima¹, M Hotta¹, E Ito², R Moriuchi¹

Affiliations

¹ Department of Dermatology, Sapporo City General Hospital, North 11, West 13, Chuo-Ku, Sapporo, Hokkaido, 060-8604, Japan.
² Iwata Dermatology Clinic, North 26, East 6-1-28, Higashi-Ku, Sapporo, Hokkaido, 065-0026, Japan.

PMID: 29194784
DOI: 10.1111/jdv.14727

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Diclofenac / administration & dosage*
Etretinate / administration & dosage*
Female
Gels
Humans
Porokeratosis / drug therapy*
Skin Diseases / drug therapy*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Gels
Diclofenac
Etretinate